Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00689715 : Efficacy Study of EUS-guided Ethanol Lavage With Paclitaxel Injection for Cystic Tumors of the Pancreas
PhasePhase 2/Phase 3
AgesMin: 20 Years Max: 85 Years
Eligibility
Inclusion Criteria:

- uni- or oligo-locular cystic tumors

- indeterminate cystic tumors for which EUS-guided fine needle aspiration (FNA) was
required to obtain additional information

- cystic tumors that increased in size during the observation period

Exclusion Criteria:

- cystic tumors which had the typical morphology of serous cystadenomas (i.e.,
honeycomb appearance) and pseudocysts (i.e., parenchymal changes)

- evidence of communication between the cystic lesion and the main pancreatic duct
according to endoscopic retrograde pancreatograms

- overt carcinomas with peripancreatic invasion

- patients with a bleeding tendency (prothrombin time > 1.5 international normalized
ratio [INR] or platelet count < 50,000/?L).
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00689715      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740